Optomed Oyj Dividends and Buybacks

Dividend criteria checks 0/6

Optomed Oyj does not have a record of paying a dividend.

Key information

n/a

Dividend yield

-10.2%

Buyback Yield

Total Shareholder Yield-10.2%
Future Dividend Yield0%
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

No updates

Recent updates

Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Sep 27
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63

May 11
Earnings Update: Here's Why Analysts Just Lifted Their Optomed Oyj (HEL:OPTOMED) Price Target To €6.63

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost

May 10
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 26% Share Price Boost

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Mar 22
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Dec 21
Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Nov 15
Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Aug 09
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Jun 01
Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Oct 27
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Apr 23
Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if OPTOMED's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if OPTOMED's dividend payments have been increasing.


Dividend Yield vs Market

Optomed Oyj Dividend Yield vs Market
How does OPTOMED dividend yield compare to the market?
SegmentDividend Yield
Company (OPTOMED)n/a
Market Bottom 25% (FI)2.9%
Market Top 25% (FI)6.3%
Industry Average (Medical Equipment)1.6%
Analyst forecast (OPTOMED) (up to 3 years)0%

Notable Dividend: Unable to evaluate OPTOMED's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate OPTOMED's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate OPTOMED's payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as OPTOMED has not reported any payouts.


Discover strong dividend paying companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/10 19:17
End of Day Share Price 2025/01/10 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Optomed Oyj is covered by 4 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kristofer Liljeberg-SvenssonCarnegie Investment Bank AB
Juha KinnunenInderes Oy
Gergana AlmquistRedeye